Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-046392
Filing Date
2018-08-13
Accepted
2018-08-13 16:04:32
Documents
1
Period of Report
2018-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3170
  Complete submission text file 0001209191-18-046392.txt   4585
Mailing Address C/O JAVELIN PHARMACEUTICALS, INC. 125 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address
Driscoll Martin J (Reporting) CIK: 0001339402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37718 | Film No.: 181012273

Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Issuer) CIK: 0001566373 (see all company filings)

EIN.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations